ADVERTISEMENT

Managing Cancer-Related Fatigue

Many patients feel sick and tired from treatment and their cancer, but there are ways to manage it.

BY BARBARA SADICK
PUBLISHED TUESDAY, MARCH 12, 2013
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Fatigue is the most common side effect of cancer and its treatment, and it varies in degree from patient to patient. It can be sporadic or constant, and, in some cases, is more intense and debilitating than “normal” fatigue. At its most intense, it can’t be relieved by sleep and is often described as “paralyzing.” It affects physical, emotional and social quality of life and is characterized by a lack of energy and motivation, total body exhaustion, a feeling of heaviness, an inability to concentrate or remember, and anxiety. Patients should discuss fatigue with their healthcare providers, who can suggest coping mechanisms and solutions, and can help them understand that such exhaustion doesn’t necessarily mean the cancer has worsened or recurred.

Fatigue is experienced by up to 90 percent of cancer patients and is caused by side effects of cancer treatments or by the cancer itself. Like the fatigue, causes vary from person to person and are often due to metabolic changes. Some cancers increase the body’s need for energy, weaken muscles and alter hormone levels. Others release proteins called cytokines, which appear to increase fatigue.

Little is known about cancer-related fatigue, but one cause may be the destruction of healthy cells in addition to those targeted for treatment and the amount of energy needed to repair and heal damaged tissues. Anemia, nausea, vomiting, pain, insomnia and mood change often occur during and after treatment and can lead to extreme fatigue.

The following are common causes of fatigue:

> Chemotherapy, radiation, bone marrow transplantation and surgery, particularly chemotherapies that stop bone marrow from making enough red blood cells to carry oxygen to the body;

> Biologic therapies that use the body’s immune system to fight cancer;

> Treatment-related hormonal changes to thyroid and adrenal glands, testes and ovaries;

> Treatment-related nutrient deficiencies;

> Sleep disorders, anxiety, depression and difficulty learning and remembering (attention fatigue); and

> Medication to treat other conditions and side effects, especially pain.

Following cancer treatment, most survivors want to resume a lifestyle free from cancer-related fatigue. The American Cancer Society estimates, though, that 30 to 50 percent of cancer survivors experience persistent fatigue for months and, sometimes years. It’s important to continue to consult with physicians, as underlying medical conditions that exacerbate the problem can often be treated. While more research is needed in this area, the following are some ways in which symptoms of fatigue can be managed:

> Medications: Stimulants, such as Ritalin (methylphenidate) and modafinil, might help but must be prescribed and monitored by a physician.

> Diet and Nutrition: Small, well-balanced, highprotein meals can provide energy. Ample fluid and limited caffeine and alcohol intake may prevent dehydration.

> Exercise: Regular exercise routines can increase energy levels, lower blood pressure, improve the ability of the heart to pump blood and increase endurance. Evidence indicates that aerobic exercise, such as walking, cycling or swimming, can help alleviate fatigue.

> Sleep and Relaxation: Sleep quality can be improved by practicing relaxation exercises before sleep, avoiding long afternoon naps and setting (and keeping) a sleep schedule.

> Complementary Therapies: Acupuncture can reduce pain and nausea by increasing the body’s blood flow and natural painkillers. Practicing visual guided imagery, meditation and mind/body exercises, such as qigong, tai chi and yoga, can also help.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
ADVERTISEMENT
ShareYourStory
Related Articles
Seeing Red
BY MICHAEL A. POSTOW
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
Chemo Use Does Not Improve Quality of Life Near Death
BY ANDREW J. ROTH
Though many patients with cancer are offered chemotherapy as palliative care during end-of-life treatment, its benefit has not been well studied previously.
Breast Reduction or Mastectomy: Yoga and Cancer
BY JEAN DI CARLO-WAGNER
There was only one problem. I had scheduled a breast reduction surgery with a private plastic surgeon. The accidental overlap of drawing blood for genetic testing, and my surgery date made, me stop and think. Would I do anything differently?
Zyprexa Relieves Nausea in Patients Treated for Head and Neck Cancer
BY LAURA MARTIN
Nausea and vomiting associated with anticancer therapies continue to be among patients’ most troubling symptoms.
IV Emend Helps Prevent CINV With Moderately Emetogenic Chemotherapy
BY LAUREN M. GREEN
A single intravenous dose of EMEND for Injection was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against CINV in patients receiving moderately emetogenic chemotherapy.
Related Videos
Cokie Roberts on Addressing the Whole Person During Treatment
BY COKIE ROBERTS
Cokie Roberts, a journalist, discusses the importance of addressing the whole person during treatment.
Patrick I. Borgen on Cancer-Related Pain Relief With Exparel
BY PATRICK I. BORGEN
Patrick I. Borgen, chair, Department of Surgery, director, Maimonides Breast Cancer Center, provides an overview of cancer-related pain relief with Exparel.
Patrick I. Borgen Discusses Opioids for Treating Cancer-Related Pain
BY PATRICK I. BORGEN
Patrick I. Borgen, chair, Department of Surgery, director, Maimonides Breast Cancer Center, comments on opioid use for cancer-related pain.
Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process
BY REP. FRANK PALLONE JR.
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.
Anya Prince on Insurance Coverage for Preventative Services
BY ANYA PRINCE
Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.
$auto_registration$
VSEO N/A